AKORN/ US0097281069 /
- - | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
-USD | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | - | - |
GlobeNewswire
08/11/2023
ANI Pharmaceuticals Reports Record Third Quarter 2023 Financial Results and Raises Full-Year 2023 Gu...
GlobeNewswire
27/09/2023
Ocuphire Pharma and Viatris Announce FDA Approval of RYZUMVI™ (Phentolamine Ophthalmic Solution) 0.7...
GlobeNewswire
03/02/2022
Prestige Consumer Healthcare Inc. Reports Fiscal 2022 Third Quarter Results
GlobeNewswire
04/11/2021
Prestige Consumer Healthcare Inc. Reports Fiscal 2022 Second Quarter Results
GlobeNewswire
18/10/2021
Avelas makes senior appointments and provides update on pegloprastide Phase III clinical program
GlobeNewswire
05/08/2021
Prestige Consumer Healthcare Inc. Reports Fiscal 2022 First Quarter Results
GlobeNewswire
01/07/2021
Prestige Consumer Healthcare Completes Acquisition of TheraTears, Announces First Quarter Fiscal 202...
GlobeNewswire
27/05/2021
Prestige Announces Agreement to Expand Eye Care Offering with Acquisition of TheraTears
GlobeNewswire
07/12/2020
Oyster Point Pharma Strengthens Executive Leadership Team with the Appointment of Chief Medical and ...
GlobeNewswire
22/06/2020
Akorn Animal Health Announces Launch of Neomycin and Polymyxin B Sulfates, and Bacitracin Zinc Ophth...
GlobeNewswire
08/06/2020
Delisting of Securities of Centric Brands Inc.; Akorn, Inc.; and Scienjoy Holding Corporation from T...
GlobeNewswire
14/11/2019
Atlas Nanotech Targets the World’s Largest Consumer Health Products Companies to License the FirstEv...
GlobeNewswire
14/10/2019
Akorn Receives FDA Approval for Betamethasone Dipropionate Lotion USP (Augmented), 0.05%
GlobeNewswire
14/10/2019
Akorn to Report Third Quarter 2019 Financial Results and Host Conference Call
GlobeNewswire
26/08/2019
Akorn Receives FDA Approval for Azelastine Hydrochloride Nasal Spray, 0.15%